Takeda Pharmaceutical Company Ltd
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
A Study of TAK-881 in Healthy Adults
- Conditions
- Healthy Volunteers
- Interventions
- Biological: TAK-881
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- Takeda
- Target Recruit Count
- 24
- Registration Number
- NCT05059977
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Hialeah, Florida, United States
A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India
- First Posted Date
- 2021-09-27
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- Takeda
- Target Recruit Count
- 5
- Registration Number
- NCT05058391
- Locations
- 🇮🇳
JK Lone Hospital, Jaipur, Rajasthan, India
🇮🇳Institute of Child Health, Kolkata, India
🇮🇳SAT Hospital - Govt Medical College, Thiruvananthapuram, Kerala, India
A Study of Real-World Outcomes of People With Crohn's Disease (CD)
- Conditions
- Crohn Disease
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2022-10-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 623
- Registration Number
- NCT05056441
- Locations
- 🇦🇺
Concord Repatriation General Hospital, Concord, New South Wales, Australia
🇦🇺Mater Misericordiae Health Services, South Brisbane, Queensland, Australia
🇦🇺Integrated Gut Health Pty Ltd, Taringa, Queensland, Australia
An Additional Analysis of Data from the PARADIGM Exploratory Study (NCT02394834) in Patients with Advanced/Recurrent Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Drug: mFOLFOX6 + panitumumab combination therapyDrug: mFOLFOX6 + bevacizumab combination therapy
- First Posted Date
- 2021-09-01
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Takeda
- Target Recruit Count
- 787
- Registration Number
- NCT05030493
- Locations
- 🇯🇵
Takeda selected site, Tokyo, Japan
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Takeda
- Target Recruit Count
- 3
- Registration Number
- NCT05027308
- Locations
- 🇯🇵
University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan
🇯🇵Kagoshiha University Hospital, Kagoshima, Japan
🇯🇵Tohoku University Hospital, Sendai, Miyagi, Japan
A Study of Danavorexton in Anesthetized Adults
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Takeda
- Target Recruit Count
- 28
- Registration Number
- NCT05025397
- Locations
- 🇺🇸
Endeavor Clinical Trials, San Antonio, Texas, United States
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Takeda
- Target Recruit Count
- 120
- Registration Number
- NCT05023382
- Locations
- 🇯🇵
Takeda selected site, Tokyo, Japan
🇯🇵Takeda Selected Site, Tokyo, Japan
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Takeda
- Target Recruit Count
- 354
- Registration Number
- NCT05021562
- Locations
- 🇯🇵
Takeda Selected Site, Tokyo, Japan
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Conditions
- Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Interventions
- Drug: Chemotherapy Agents
- First Posted Date
- 2021-08-25
- Last Posted Date
- 2025-05-01
- Lead Sponsor
- Takeda
- Target Recruit Count
- 27
- Registration Number
- NCT05020015
- Locations
- 🇺🇸
Cedars Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States
🇺🇸Northside Hospital, Atlanta, Georgia, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Other: No intervention
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Takeda
- Target Recruit Count
- 320
- Registration Number
- NCT05013190
- Locations
- 🇨🇳
Anhui Cancer Hospital, Hefei, Anhui, China
🇨🇳Beijing Chao-Yang Hospital,Capital Medical University, Beijing, Beijing, China
🇨🇳Beijing Jishuitan Hospital, Beijing, Beijing, China